206 related articles for article (PubMed ID: 24620022)
21. Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice.
Heimesaat MM; Mrazek K; Bereswill S
Sci Rep; 2019 Dec; 9(1):19797. PubMed ID: 31875037
[TBL] [Abstract][Full Text] [Related]
22. Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10
Brudvig JM; Cluett MM; Gensterblum-Miller EU; Chen J; Bell JA; Mansfield LS
Comp Med; 2022 Apr; 72(2):63-77. PubMed ID: 35272743
[No Abstract] [Full Text] [Related]
23. An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model.
Brooks PT; Bell JA; Bejcek CE; Malik A; Mansfield LS
J Neuroimmunol; 2019 Dec; 337():577048. PubMed ID: 31678855
[TBL] [Abstract][Full Text] [Related]
24.
Bereswill S; Grundmann U; Alutis ME; Fischer A; Heimesaat MM
Gut Pathog; 2017; 9():5. PubMed ID: 28127403
[TBL] [Abstract][Full Text] [Related]
25. Peptidase PepP is a novel virulence factor of
Heimesaat MM; Schmidt AM; Mousavi S; Escher U; Tegtmeyer N; Wessler S; Gadermaier G; Briza P; Hofreuter D; Bereswill S; Backert S
Gut Microbes; 2020 Nov; 12(1):1770017. PubMed ID: 32584649
[TBL] [Abstract][Full Text] [Related]
26. Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.
Mansfield LS; Patterson JS; Fierro BR; Murphy AJ; Rathinam VA; Kopper JJ; Barbu NI; Onifade TJ; Bell JA
Microb Pathog; 2008 Oct; 45(4):241-57. PubMed ID: 18586081
[TBL] [Abstract][Full Text] [Related]
27. Outcome of infection of C57BL/6 IL-10(-/-) mice with Campylobacter jejuni strains is correlated with genome content of open reading frames up- and down-regulated in vivo.
Bell JA; Jerome JP; Plovanich-Jones AE; Smith EJ; Gettings JR; Kim HY; Landgraf JR; Lefébure T; Kopper JJ; Rathinam VA; St Charles JL; Buffa BA; Brooks AP; Poe SA; Eaton KA; Stanhope MJ; Mansfield LS
Microb Pathog; 2013 Jan; 54():1-19. PubMed ID: 22960579
[TBL] [Abstract][Full Text] [Related]
28. Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity.
Bereswill S; Fischer A; Plickert R; Haag LM; Otto B; Kühl AA; Dasti JI; Zautner AE; Muñoz M; Loddenkemper C; Gross U; Göbel UB; Heimesaat MM
PLoS One; 2011; 6(6):e20953. PubMed ID: 21698299
[TBL] [Abstract][Full Text] [Related]
29. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
30. Treatment with the Probiotic Product Aviguard
Heimesaat MM; Weschka D; Mousavi S; Bereswill S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206478
[TBL] [Abstract][Full Text] [Related]
31. A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection.
Stahl M; Ries J; Vermeulen J; Yang H; Sham HP; Crowley SM; Badayeva Y; Turvey SE; Gaynor EC; Li X; Vallance BA
PLoS Pathog; 2014 Jul; 10(7):e1004264. PubMed ID: 25033044
[TBL] [Abstract][Full Text] [Related]
32. Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice.
Mousavi S; Escher U; Thunhorst E; Kittler S; Kehrenberg C; Bereswill S; Heimesaat MM
Sci Rep; 2020 Feb; 10(1):2921. PubMed ID: 32076081
[TBL] [Abstract][Full Text] [Related]
33. Induction of neutrophil extracellular traps by Campylobacter jejuni.
Callahan S; Doster RS; Jackson JW; Kelley BR; Gaddy JA; Johnson JG
Cell Microbiol; 2020 Aug; 22(8):e13210. PubMed ID: 32329205
[TBL] [Abstract][Full Text] [Related]
34. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
35. Oral curcumin ameliorates acute murine campylobacteriosis.
Heimesaat MM; Mousavi S; Lobo de Sá FD; Peh E; Schulzke JD; Bücker R; Kittler S; Bereswill S
Front Immunol; 2024; 15():1363457. PubMed ID: 38855111
[TBL] [Abstract][Full Text] [Related]
36. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.
Edwards LA; Nistala K; Mills DC; Stephenson HN; Zilbauer M; Wren BW; Dorrell N; Lindley KJ; Wedderburn LR; Bajaj-Elliott M
PLoS One; 2010 Nov; 5(11):e15398. PubMed ID: 21085698
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cytokine production and phagocytic activity in mice infected with Campylobacter jejuni.
Pancorbo PL; de Pablo MA; Ortega E; Gallego AM; Alvarez C; Alvarez de Cienfuegos G
Curr Microbiol; 1999 Sep; 39(3):129-33. PubMed ID: 10441725
[TBL] [Abstract][Full Text] [Related]
38. Microbiota Composition and Immune Responses During
Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Bereswill S
Eur J Microbiol Immunol (Bp); 2017 Mar; 7(1):1-14. PubMed ID: 28386467
[TBL] [Abstract][Full Text] [Related]
39. A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni.
Zilbauer M; Dorrell N; Elmi A; Lindley KJ; Schüller S; Jones HE; Klein NJ; Núnez G; Wren BW; Bajaj-Elliott M
Cell Microbiol; 2007 Oct; 9(10):2404-16. PubMed ID: 17521327
[TBL] [Abstract][Full Text] [Related]
40. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice.
Im E; Jung J; Pothoulakis C; Rhee SH
Gastroenterology; 2014 Sep; 147(3):667-679.e10. PubMed ID: 24882466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
